Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - VYNE Therapeutics Inc. | StockGist | StockGist

Companies
VYNE
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings VYNESCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

VYNE Therapeutics Inc.

Filed Nov 14, 2025

Accepted Nov 13, 2025, 7:00 PM ET

CIK 0001566044

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

14

Reporting Person

VYNE Therapeutics Inc.

Person Type

IA

CUSIP: 92941V308

Key Facts

Shares Owned

14

Recent Filings

VYNE Therapeutics Inc.3 weeks ago

VYNE Therapeutics Inc.1 months ago

VYNE Therapeutics Inc.2 months ago

VYNE Therapeutics Inc.3 months ago

VYNE Therapeutics Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice